Skip to main content
Clinical Trials/NCT06114043
NCT06114043RecruitingNot Applicable

Randomised Controlled Trial; Is Operative Treatment of Mild to Moderate Hallux Valgus Deformity Superior to Conservative Treatment?

Ostfold Hospital Trust2 sites in 1 country120 target enrollmentStarted: June 1, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
120
Locations
2
Primary Endpoint
Clinical results MOxFQ

Study Overview

Brief Summary

The goal of this randomized controlled trial is to investigate operative treatment versus conservative treatment in participants suffering from mild to moderate hallux valgus deformity. The main question it aims to answer are; Is surgery superior to conservative treatment?

The participants will be randomized in to two groups, operative and conservative group.

Investigators will compare the groups measuring the clinical results using the patient-reported outcome measure (PROM) Manchester-Oxford Foot Questionnaire (MOxFQ), Visual analog scale (VAS), likert scale 0-5. Participants will be observed for a period og two years.

Detailed Description

Randomized controlled trial (RCT) investigating the patient reported outcome after operative or conservative treatment in mild to moderate hallux valgus deformity. In this RCT study participants will be divided into operative group, non-operative group where the treatment will be orthopedic aids/wide shoes. The participants will be evaluated 6 months, 1 year and 2 years after starting the treatment. The clinical results will be evaluated using patient reported outcome measures (PROMs).

Primary aim: Investigating the clinical result by PROM (Manchester Oxford Foot Questionnaire)

Secondary aim: Investigating the radiological results according to newer and traditional parameters. Operative group -correction achieved, residual rate. Conservative group -progression of deformity.

Statistical power calculations have been made within the research group. Calculations are based on the main outcome MOxFQ, with the power of 80 and confidence interval 95%. The investigators concluded that a sample size of 49 participants will be needed to perform a regression analysis. To account for loss to follow-up (estimated 20%),120 participants (60 per group) will be recruited.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Painful Hallux Valgus deformity
  • Hallux Valgus Angle <35 degrees
  • Intermetatarsal angle <15 degrees
  • 18-80 years

Exclusion Criteria

  • Advanced osteoarthritis in first metatarsophalangeal joint
  • Rheumatic diseases
  • Pregnancy
  • Drug abuse
  • Severe psychological disorder
  • Lack of compliance
  • Language barrier

Outcomes

Primary Outcomes

Clinical results MOxFQ

Time Frame: 2 years

Manchester oxford foot questionnaire (MOxFQ) (Raw scores can be converted to a 0-100 metric where 100=most severe)

Secondary Outcomes

  • Clinical result VAS(2 years)
  • Clinical result Likert scale(2 years)
  • Clinical result SF-36(2 years)

Investigators

Sponsor
Ostfold Hospital Trust
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marius Molund

MD, phd, head of foot & ankle department Ostfold hospital trust

Ostfold Hospital Trust

Study Sites (2)

Loading locations...

Similar Trials